Decades since the discovery of messenger RNA, mRNA-based therapeutics catapulted to the forefront of public consciousness in the form of vaccines to combat the COVID-19 pandemic.
Watch Now
genengnews
The therapeutic antibody market has reached a fever pitch of enthusiasm, in no small part due to successes of recent drug approvals for a host of disorders such as psoriasis, multiple sclerosis, C. difficile infections, and cancer.
Watch Now
Abbott Diagnostics
The movement towards value-based healthcare has provided a platform for a better future for all involved in the health ecosystem. However, amongst the multitude of value initiatives, the clinical laboratory has largely been left to play a secondary role. Despite its core value principles of data, timely and efficient diagnosis, and patient centricity, the lab has been relegated to near-commodity status. This is also indicative of a broader problem: a fragmented value chain that underexploits sources in decision-making, at a time when the health world’s stated focus is on outcomes.
Watch Now
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) supports a large network of National Centers for Biomedical Imaging and Bioengineering (NCBIB) through the P41 grant mechanism.
Watch Now